71 - Autologous Hematopoietic Cell Transplant Outcomes after Pembrolizumab Plus GVD As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Autor: Shah, Gunjan L., Moskowitz, Alison, Ganesan, Nivetha, Hancock, Helen, Davey, Theresa, Sohail, Samia, Santarosa, Alayna, Lyons, Jennifer, Ruiz, Josel D., Kumar, Anita, Batlevi, Connie W, Caron, Philip, Hamlin, Paul, Matasar, Matthew J., Rodriguez-Rivera, Ildefonso, Straus, David, von Keudell, Gottfried, Yahalom, Joachim, Dahi, Parastoo B., Lahoud, Oscar B., Scordo, Michael, Perales, Miguel, Sauter, Craig S., Moskowitz, Craig H.
Zdroj: In Transplantation and Cellular Therapy March 2021 27(3) Supplement:S68-S69
Databáze: ScienceDirect
Externí odkaz: